Evangelos Ntrivalas, MD, PhD
Diagnostic Immunology; Flow Cytometry
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Aristotle University of Thessaloniki; PhD, Rosalind Franklin University of Medicine and Science
Clinical and Diagnostic Immunology - Rosalind Franklin University of Medicine and Science
I am an immunologist with a specialty in medical laboratory immunology. I have 15 years of experience in developing and validating immunoassays (tests) to diagnose immune diseases in patients. This includes autoimmunity, immunodeficiency, and tumor immunologic diseases.
My area of expertise is flow cytometry. This specialized laboratory technique is used to detect cellular and other changes in immune cells. Using these methods, doctors can diagnose abnormal immune cells that might be cancerous and see how well immunotherapies (a form of cancer treatment that uses the immune system to attack cancer cells) are working. I am particularly interested in intracellular cytokine assay by flow cytometry. This method is used to monitor T cells after blood stem cell transplantation.
In my research, I am interested in natural killer (NK) cells and their role in protecting people from cancer. My goal is to develop flow cytometric assays to measure NK cell function as it relates to tumor immunology. NK cells are also used for immunotherapy. Chimeric antigen receptor NK (CAR-NK) cells are being engineered for cancer treatments. NK flow cytometric assays can help identify unique markers in CAR-NK cells.
Outside of the office, I enjoy spending time outdoors with my wife and two children. Hiking and swimming are among our favorite activities. I also enjoy cooking.
Awards and Honors
- AACC Speaker Recognition Award
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Evangelos Ntrivalas discloses the following relationships and financial interests:
Association of Medical Laboratory Immunologists (AMLI)
Provision of Services (uncompensated)
International Federation of Clinical Chemistry and Laboratory Medicine
Provision of Services (uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.